Tonix Pharmaceuticals Holding Corp (TNXP) expanding its growth trajectory ahead

With 1.02 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.51 million shares. The 52-week range on TNXP shows that it touched its highest point at $672.00 and its lowest point at $6.76 during that stretch. It currently has a 1-year price target of $70.00. Beta for the stock currently stands at 1.65.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TNXP was up-trending over the past week, with a rise of 14.97%, but this was up by 11.95% over a month. Three-month performance surged to 0.46% while six-month performance rose 26.81%. The stock lost -96.54% in the past year, while it has lost -40.63% so far this year. A look at the trailing 12-month EPS for TNXP yields -29.46 with Next year EPS estimates of -4.67. For the next quarter, that number is -3.09. This implies an EPS growth rate of 93.27% for this year and 60.72% for next year.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TNXP since 5 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$7.47007 being high and -$219.52993 being low. For TNXP, this leads to a yearly average estimate of -$113.5.